-
1
المؤلفون: Olalekan O. Oluwole, Sattva S. Neelapu, Jun Kawashima, Matthew L. Ulrickson, Lovely Goyal, Yin Yang, Catherine Thieblemont, Sven de Vos, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Natasha Kekre, Michael Dickinson, Julio C. Chavez, Francesca Milletti, Peter A. Riedell
المصدر: Transplantation and Cellular Therapy. 27:S3-S4
مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, business.industry, Phases of clinical research, Cell Biology, Hematology, medicine.disease, Interim analysis, First line therapy, Internal medicine, medicine, Molecular Medicine, Immunology and Allergy, In patient, B-cell lymphoma, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d3f1bae57badbc5270dfa74ca9e2e325Test
https://doi.org/10.1016/s2666-6367Test(21)00030-0 -
2
المؤلفون: Chaitra S. Ujjani, Lovely Goyal, Yi Lin, Sven de Vos, Michael Dickinson, Francesca Milletti, Catherine Thieblemont, Yin Yang, Julio C. Chavez, Alex F. Herrera, Peter A. Riedell, Jun Kawashima, Olalekan O. Oluwole, Sattva S. Neelapu, Matthew L. Ulrickson, Natasha Kekre
المصدر: Blood. 136:49-49
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Phases of clinical research, Cell Biology, Hematology, Interim analysis, Biochemistry, First line therapy, White blood cell count decreased, Family medicine, medicine, LUGANO CLASSIFICATION, In patient, business, Bristol-Myers, Clin oncol
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::25ee880ed44d712074523335aab90a4eTest
https://doi.org/10.1182/blood-2020-134449Test -
3
المؤلفون: Chaitra S. Ujjani, Lovely Goyal, Javier Munoz, Sven de Vos, Yi Lin, Natasha Kekre, Jun Kawashima, Alex F. Herrera, Francesca Milletti, Sattva S. Neelapu, Olalekan O. Oluwole, Julio C. Chavez, Kate Backhouse, Peter A. Riedell, Yin Yang
المصدر: Journal of Clinical Oncology. 37:TPS7574-TPS7574
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.disease, 03 medical and health sciences, Persistent Disease, 0302 clinical medicine, Increased risk, First line therapy, Multicenter study, 030220 oncology & carcinogenesis, Induction therapy, Internal medicine, Medicine, Rituximab, In patient, business, B-cell lymphoma, 030215 immunology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0755a2f30c26083a17d92455275501b3Test
https://doi.org/10.1200/jco.2019.37.15_suppl.tps7574Test